| Year | Paper |
|---|---|
| 2012 | Abdel-Wahab O, Pardanani A, Bernard OA, Finazzi G, Crispino JD, Gisslinger H, Kralovics R, Odenike O, Bhalla K, Gupta V, Barosi G, Gotlib J, Guglielmelli P, Kiladjian JJ, Noel P, Cazzola M, Vannucchi AM, Hoffman R, Barbui T, Thiele J, Van Etten RA, Mughal T, Tefferi A. Unraveling the genetic underpinnings of myeloproliferative neoplasm and understanding their effect on disease course and response to therapy: proceedings from the 6th International Post-ASH Symposium. Am J Hematol. 2012 May;87(5):562-8. doi: 10.1002/ajh.23169. Epub 2012 Mar 28. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22460584 |
| 2012 | Adams D, Altucci L, Antonarakis SE, Ballesteros J, Beck S, Bird A, Bock C, Boehm B, Campo E, Caricasole A, Dahl F, Dermitzakis ET, Enver T, Esteller M, Estivill X, Ferguson-Smith A, Fitzgibbon J, Flicek P, Giehl C, Graf T, Grosveld F, Guigo R, Gut I, Helin K, Jarvius J, Kuppers R, Lehrach H, Lengauer T, Lernmark A, Leslie D, Loeffler M, Macintyre E, Mai A, Martens JH, Minucci S, Ouwehand WH, Pelicci PG, Pendeville H, Porse B, Rakyan V, Reik W, Schrappe M, Schubeler D, Seifert M, Siebert R, Simmons D, Soranzo N, Spicuglia S, Stratton M, Stunnenberg HG, Tanay A, Torrents D, Valencia A, Vellenga E, Vingron M, Walter J, Willcocks S. BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol 30, 224-226. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22398613 |
| 2012 | Amir S, Hartvigsen K, Gonen A, Leibundgut G, Que X, Jensen-Jarolim E, Wagner O, Tsimikas S, Witztum JL, Binder CJ. Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease. J Lipid Res. 2012 Jul;53(7):1316-26. Epub 2012 Apr 16. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22508944 |
| 2012 | Bento C, Maia TM, Milosevic JD, Carreira IM, Kralovics R, Ribeiro ML. Beta thalassemia major due to acquired uniparental disomy in a previously healthy adolescent. Haematologica. 2012 Aug 8. [Epub ahead of print]. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22875618 |
| 2012 | Bieghs V, van Gorp PJ, Walenbergh SM, Gijbels MJ, Verheyen F, Buurman WA, Briles DE, Hofker MH, Binder CJ, Shiri-Sverdlov R. Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice. Hepatology. 2012 Sep;56(3):894-903. doi: 10.1002/hep.25660. Epub 2012 Jul 6. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22334337 |
| 2012 | Bieghs V, Van Gorp PJ, Wouters K, Hendrikx T, Gijbels MJ, van Bilsen M, Bakker J, Binder CJ, Lutjohann D, Staels B, Hofker MH, Shiri-Sverdlov R. LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease. PLoS One 7:e30668. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22295101 |
| 2012 | Bieghs V, Verheyen F, van Gorp PJ, Hendrikx T, Wouters K, Lütjohann D, Gijbels MJ, Febbraio M, Binder CJ, Hofker MH, Shiri-Sverdlov R. Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells. PLoS One. 2012;7(3):e34378. Epub 2012 Mar 28. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22470565 |
| 2012 | Bock C, Beerman I, Lien WH, Smith ZD, Gu H, Boyle P, Gnirke A, Fuchs E, Rossi DJ, Meissner A. Genome-scale dynamics of DNA methylation during blood and skin stem cell differentiation. Mol Cell 2012 Aug 24;47(4):633-47. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22841485 |
| 2012 | Bock C, Lengauer T. Managing drug resistance in cancer: lessons from HIV therapy. Nat Rev Cancer. 2012 Jun 7;12(7):494-501. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22673150 |
| 2012 | Bock C. Analysing and interpreting DNA methylation data. Nat Rev Genet. 2012 Oct;13(10):705-19. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22986265 |
| 2012 | Clarke M, Dumon S, Ward C, Jäger R, Freeman S, Dawood B, Sheriff L, Lorvellec M, Kralovics R, Frampton J, García P. MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia. Leukemia. 2012 Aug 22. doi: 10.1038/leu.2012.241. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22910183 |
| 2012 | Colinge J, Rix U, Bennett KL, Superti-Furga G. Systems biology analysis of protein-drug interactions. Proteomics Clin. Appl. 2012 Jan;6(1-2):102-16. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22213655 |
| 2012 | Doring Y, Manthey H, Drechsler M, Lievens D, Megens R, Soehnlein O, Busch M, Manca M, Koenen RR, Pelisek J, Daemen MJ, Lutgens E, Zenke M, Binder CJ, Weber C, Zernecke A. Auto-Antigenic Protein-DNA Complexes Stimulate Plasmacytoid Dendritic Cells to Promote Atherosclerosis. Circulation 2012 Apr 3;125(13):1673-83. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22388324 |
| 2012 | Elsoe S, Ahnstrom J, Christoffersen C, Hoofnagle AN, Plomgaard P, Heinecke JW, Binder CJ, Bjorkbacka H, Dahlback B, Nielsen LB. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL. Atherosclerosis 221:91-97. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22204862 |
| 2012 | Fomina-Yadlin D, Kubicek S, Vetere A, Hu He K, Schreiber SL, Wagner BK. GW8510 increases insulin expression in pancreatic alpha cells through activation of p53 transcriptional activity. PLOS one7(1): e28808. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22242153 |
| 2012 | Frogne T, Sylvestersen KB, Kubicek S, Nielsen ML, Hecksher-Sørensen J. Pdx1 is post-translationally modified in vivo and serine 61 is the principal site of phosphorylation. PLoS One. 2012;7(4):e35233. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22509401 |
| 2012 | Goncalves A, Karayel E, Rice GI, Bennett KL, Crow YJ, Superti-Furga G, Bürckstümmer T. SAMHD1 is a nucleic acid-binding protein that is mislocalised due to Aicardi-Goutières syndrome-associated mutations. Human Mut. 2012 Jul;33(7):1116-22. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22461318 |
| 2012 | Guenzl PM, Barlow DP. Macro lncRNAs – a new layer of cis-regulatory information in the mammalian genome. RNA Biology. Jun 1;9(6). [Epub ahead of print]. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22617879 |
| 2012 | Halachev K, Bast H, Albrecht F, Lengauer T, Bock C. EpiExplorer: live exploration and global analysis of large epigenomic datasets. Genome Biol. 2012 Oct 3;13(10):R96. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23034089 |
| 2012 | Hantschel O, Grebien F, Superti-Furga G. The growing arsenal of ATP-competitive and allosteric inhibitors of BCR-ABL. Cancer Res. 2012 Oct 1;72(19):4890-5. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23002203 |
| 2012 | Hantschel O, Superti-Furga G. Cell biology: a key driver of therapeutic innovation. J Cell Biol. 2012 Nov 12;199(4):571-5. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23148230 |
| 2012 | Hantschel O, Warsch W, Eckelhart E, Kaupe I, Grebien F, Wagner KU, Superti-Furga G, Sexl V. BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. Nat Chem Biol. 2012 Jan 29;8(3):285-93. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22286129 |
| 2012 | Harutyunyan AS, Kralovics R. Role of germline genetic factors in MPN pathogenesis. Hematol Oncol Clin North Am. 2012 Oct;26(5):1037-51. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23009936 |
| 2012 | Heo S, Yang JW, Huber ML, Planyavsky M, Bennett KL, Lubec G. Mass spectrometric characterization of recombinant rat 5-hydroxytryptamine receptor 1A (5-HT(1A) R) expressed in tsA201 human embryonic kidney cells. Proteomics. 2012 Nov;12(22):3338-42. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22997067 |
| 2012 | Hopkins S, Linderoth E, Hantschel O, Suarez-Henriques P, Pilia G, Kendrick H, Smalley MJ, Superti-Furga G, Ferby I. Mig6 is a sensor of EGF receptor inactivation that directly activates c-Abl to induce apoptosis during epithelial homeostasis. Dev Cell. 2012 Sep 11;23(3):547-59. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22975324 |
| 2012 | Kachaner D, Filipe J, Laplantine E, Bauch A, Bennett KL, Superti-Furga G, Israël A, Weil R. Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression, Mol. Cell. 45, 553-66. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22365832 |
| 2012 | Knapp S. Animal Models of Sepsis. Section Editor of this issue and Editorial. Drug Discovery Today – Disease Models Jan 2012. Abstract: |
| 2012 | Koerner MV, Pauler FM, Hudson QJ, Santoro F, Sawicka A, Guenzl PM, Stricker SH, Schichl YM, Latos PA, Klement RM, Warczok KE, Wojciechowski J, Seiser C, Kralovics R, Barlow DP. A downstream CpG island controls transcript initiation and elongation and the methylation state of the imprinted Airn macro ncRNA promoter. PLoS Genet. 2012;8(3):e1002540. Epub 2012 Mar 1. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22396659 |
| 2012 | Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O, Boztug K, Pfeifer D, Kreipe H, Pfister ED, Baumann U, Puchalka J, Bohne J, Egritas O, Dalgic B, Kolho KL, Sauerbrey A, Buderus S, Güngör T, Enninger A, Koda YK, Guariso G, Weiss B, Corbacioglu S, Socha P, Uslu N, Metin A, Wahbeh GT, Husain K, Ramadan D, Al-Herz W, Grimbacher B, Sauer M, Sykora KW, Koletzko S, Klein C. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012 Aug;143(2):347-55. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22549091 |
| 2012 | Kubicek S, Gilbert JC, Fomina-Yadlin D, Gitlin AD, Yuan Y, Wagner FF, Holson EB, Luo T, Lewis TA, Taylor B, Gupta S, Shamji A, Wagner BK, Clemons PA, Schreiber S.L. Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells. PNAS 2012 Apr 3;109(14):5364-9. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22434908 |
| 2012 | Latos PA, Pauler FM, Koerner MV, _energin HB, Hudson QJ, Stocsits RR, Allhoff W, Stricker SH, Klement RM, Warczok KE, Aumayr K, Pasierbek P, Barlow DP. Airn transcriptional overlap, but not its lncRNA products, induces imprinted Igf2r silencing. Science. 2012 Dec 14;338(6113):1469-72. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23239737 |
| 2012 | Lievens D, Habets KL, Robertson AK, Laouar Y, Winkels H, Rademakers T, Beckers L, Wijnands E, Boon L, Mosaheb M, Ait-Oufella H, Mallat Z, Flavell RA, Rudling M, Binder CJ, Gerdes N, Biessen EA, Weber C, Daemen MJ, Kuiper J, Lutgens E. Abrogated transforming growth factor beta receptor II (TGF_RII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis. Eur Heart J. 2012 May 21. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22613345 |
| 2012 | Litvak V, Ratushny AV, Lampano AE, Schmitz F, Huang AC, Raman A, Rust AG, Bergthaler A, Aitchison JD, Aderem A. A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature. 2012 Oct 18;490(7420):421-5. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22982991 |
| 2012 | Maurer M, Müller AC, Wagner C, Huber ML, Rudashevskaya EL, Wagner SN, Bennett KL. Combining Filter-Aided Sample Preparation and Pseudoshotgun Technology To Profile the Proteome of a Low Number of Early Passage Human Melanoma Cells. J Proteome Res. 2012 Dec 24. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23214492 |
| 2012 | Mekhoubad S, Bock C, Egli D, De Boer S, Kiskinis E, Meissner A, Eggan K. Erosion of Dosage Compensation Impacts Human iPSC Disease Modeling. Cell Stem Cell 2012 May 4;10(5):595-609. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22560080 |
| 2012 | Mikeska T, Bock C, Do H, Dobrovic A. DNA methylation biomarkers in cancer: progress towards clinical implementation. Expert Review of Molecular Diagnostics. Expert Rev Mol Diagn. 2012 Jun;12(5):473-87. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22702364 |
| 2012 | Milosevic JD, Kralovics R. Genetic and epigenetic alterations of myeloproliferative disorders. Int J Hematol. 2012 Dec 12. [Epub ahead of print]. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23233154 |
| 2012 | Milosevic JD, Puda A, Malcovati L, Berg T, Hofbauer M, Stukalov A, Klampfl T, Harutyunyan AS, Gisslinger H, Gisslinger B, Burjanivova T, Rumi E, Pietra D, Elena C, Vannucchi AM, Doubek M, Dvorakova D, Robesova B, Wieser R, Koller E, Suvajdzic N, Tomin D, Tosic N, Colinge J, Racil Z, Steurer M, Pavlovic S, Cazzola M, Kralovics R. Clinical significance of genetic aberrations in secondary acute myeloid leukemia. Am J Hematol. 2012 Nov;87(11):1010-6. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22887079 |
| 2012 | Müller AC, Breitwieser FP, Fischer H, Schuster C, Brandt O, Colinge J, Superti-Furga G, Stingl G, Elbe-Buerger A, Bennett KL. A comparative proteomic study of human skin suction blister fluid from healthy individuals using immunodepletion and iTRAQ-labelling. J. Proteome Res. 2012 Jul 6;11(7):3715-27. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22578099 |
| 2012 | Papac-Milicevic N, Breuss JM, Zaujec J, Ryban L, Plyushch T, Wagner GA, Fenzl S, Dremsek P, Cabaravic M, Steiner M, Glass CK, Binder CJ, Uhrin P, Binder BR. The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors. Circulation Research. 2012 Apr 13;110(8):e50-63. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22427340 |
| 2012 | Pauler FM, Barlow DP, Hudson QJ. Mechanisms of long range silencing by imprinted macro non-coding RNAs. Curr Opin Genet Dev. 2012 Jun;22(3):283-9. Epub 2012 Mar 3. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22386265 |
| 2012 | Pichlmair A, Kandasamy K, Alvisi G, Mulhern O, Sacco R, Habjan M, Binder M, Stefanovic A, Eberle CA, Goncalves A, Bürckstümmer T, Müller AC, Fauster A, Holze C, Lindsten K, Goodbourn S, Kochs G, Weber F, Bartenschlager R, Bowie AG, Bennett KL, Colinge J, Superti-Furga G. Viral immune modulators perturb the human molecular network by common and unique strategies. Nature. 2012 Jul 26;487(7408):486-90. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22810585 |
| 2012 | Pollreisz A, Funk M, Breitwieser FP, Parapatics K, Sacu S, Georgopoulos M, Dunavoelgyi R, Zlabinger GJ, Colinge J, Bennett KL, Schmidt-Erfurth U. Quantitative proteomics of aqueous and vitreous fluid from patients with idiopathic epiretinal membranes. Exp Eye Res. 2012 Nov 29;108C:48-58. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23201028 |
| 2012 | Puda A, Milosevic JD, Berg T, Klampfl T, Harutyunyan AS, Gisslinger B, Rumi E, Pietra D, Malcovati L, Elena C, Doubek M, Steurer M, Tosic N, Pavlovic S, Guglielmelli P, Pieri L, Vannucchi AM, Gisslinger H, Cazzola M, Kralovics R. Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. Am J Hematol. 2012 Mar;87(3):245-50. doi: 10.1002/ajh.22257. Epub 2011 Dec 21. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22190018 |
| 2012 | Rudashevskaya EL, Sacco R, Kratochwill K, Huber ML, Gstaiger M, Superti-Furga G, Bennett KL. A method to resolve the composition of heterogeneous affinity-purified protein complexes assembled around a common protein by chemical cross-linking, gel electrophoresis and mass spectrometry. Nat Protoc. 2012 Dec 13;8(1):75-97. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23237831 |
| 2012 | Sage AP, Tsiantoulas D, Baker L, Harrison J, Masters L, Binder CJ, Mallat Z. BAFF (B Cell Activating Factor) Receptor Deficiency Reduces the Development of Atherosclerosis in Mice. Arterioscl Thromb Vasc Biol. 2012 Jul;32(7):1573-6. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22426131 |
| 2012 | Salzer E, Daschkey S, Choo S, Gombert M, Santos-Valente E, Ginzel S, Schwendinger M, Haas OA, Fritsch G, Pickl WF, Foerster-Waldl E, Borkhardt A, Boztug K*, Bienemann K*, Seidel MG*. Combined immunodeficiency with life-threatening EBV-associatedlymphoproliferative disorder in patients lacking functional CD27. Haematologica. 2013 Mar;98(3):473-8. doi: 10.3324/haematol.2012.068791. Epub 2012 Jul 16. (*equal contributing authors) Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22801960 |
| 2012 | Santos-Valente E, Reisli I, Artaç H, Ott R, Sanal O, Boztug K. A Novel Mutation in the Complement Component 3 Gene in a Patient with Selective IgA Deficiency. J Clin Immunol. 2013 Jan;33(1):127-33. doi: 10.1007/s10875-012-9775-z. Epub 2012 Sep 21. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22996269# |
| 2012 | Sigel S, Bunk S, Meergans T, Doninger B, Stich K, Stulnig T, Derfler K, Hoffmann J, Deininger S, von Aulock S, Knapp S. Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune response in humans and mice. Eur J Immunol. 2012 Jul 18. doi: 10.1002/eji.201242564. [Epub ahead of print]. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22806614 |
| 2012 | Simmer F, Brinkman AB, Assenov Y, Matarese F, Kaan A, Sabatino L, Villanueva A, Huertas D, Esteller M, Lengauer T, Bock C, Colantuoni V, Altucci L, Stunnenberg HG. Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues. Epigenetics. 2012 Dec 1;7(12):1355-67. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23079744 |
| 2012 | Smida M, Nijman SM. Functional drug-gene interactions in lung cancer. Expert Rev. Mol. Diagn. 2012 Apr;12(3):291-302. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22468819 |
| 2012 | Stukalov A, Superti-Furga G, Colinge J. Deconvolution of targeted protein-protein interaction maps. J Proteome Res. 2012 Aug 3;11(8):4102-9. Epub 2012 Jul 10. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22724552 |
| 2012 | Sudol M, Cesareni G, Superti-Furga G, Just W. Special issue – modular protein domains. FEBS Lett. 2012 Aug 14;586(17):2571. Epub 2012 Jun 17. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22713655 |
| 2012 | Tsiantoulas D, Binder CJ. Natural Antibodies and Atherosclerosis; pp. 289-304 in Inflammation and Atherosclerosis; Springer; Edited by Georg Wick & Cecilia Grundtman. Abstract: |
| 2012 | Uras IZ, List T, Nijman SM. Ubiquitin-Specific Protease 4 Inhibits Mono-Ubiquitination of the Master Growth Factor Signaling Kinase PDK1. PloS One 2012;7(2):e31003. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22347420 |
| 2012 | Weismann D, Binder CJ. The innate immune response to products of phospholipid peroxidation. Biochim Biophys Acta. 2012 Oct;1818(10):2465-75. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22305963 |
| 2012 | Winter GE, Rix U, Carlson SM, Gleixner KV, Grebien F, Gridling M, Müller AC, Breitwieser FP, Bilban M, Colinge J, Valent P, Bennett KL, White FM, Superti-Furga G. Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML. Nat Chem Biol. 2012 Nov;8(11):905-12. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23023260 |
| 2012 | Wolf D, Jehle F, Ortiz Rodriguez A, Dufner B, Hoppe N, Colberg C, Lozhkin A, Bassler N, Rupprecht B, Wiedemann A, Hilgendorf I, Stachon P, Willecke F, Febbraio M, von zur Muhlen C, Binder CJ, Bode C, Zirlik A, Peter K. CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulations and production of pathogenic IdG-antibodies. PLoS One. 2012;7(3):e33026. Epub 2012 Mar 8. Erratum in: PLoS One. 2012;7(5): doi/10.1371/annotation/84102aae-770a-41ae-9c15-4736ed129c17. von zur Muhlen, Constantin [added]. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22412980 |
| 2012 | Yuan Y, Wang Q, Paulk J, Kubicek S, Kemp MM, Adams DJ, Shamji AF, Wagner BK, Schreiber SL. A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma. ACS Chem Biol. 2012 Jul 20;7(7):1152-7. Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22536950 |
| 2012 | Laimer, D., H. Dolznig, K. Kollmann, P.W. Vesely, M. Schlederer, O. Merkel, A.I. Schiefer, M.R. Hassler, S. Heider, L. Amenitsch, C. Thallinger, P.B. Staber, I. Simonitsch-Klupp, M. Artaker, S. Lagger, S.D. Turner, S. Pileri, P.P. Piccaluga, P. Valent, K. Messana, I. Landra, T. Weichhart, S. Knapp, M. Shehata, M. Todaro, V. Sexl, G. Hofler, R. Piva, E. Medico, B.A. Ruggeri, M. Cheng, R. Eferl, G. Egger, J.M. Penninger, U. Jaeger, R. Moriggl, G. Inghirami, and L. Kenner, PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nat Med, 2012. 18(11): p. 1699-704. Abstract: https://www.ncbi.nlm.nih.gov/pubmed/23064464 |